{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:31Z","timestamp":1761896551937,"version":"build-2065373602"},"reference-count":20,"publisher":"Wiley","issue":"17","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>The model and approach described by Howlader et al could form a foundation for future risk\u2010prediction models that incorporate data on known differences in demographic, socioeconomic, clinical, and biological factors. Data from large diffuse large B\u2010cell lymphoma patient cohorts that capture host and tumor genomics and known clinical prognostic factors will be necessary to provide the resources for constructing meaningful prognostic models and to establish prediction models that will allow us to limit therapy and therapy\u2010related toxicity for favorable subsets of patients while optimizing directed approaches for poor\u2010risk subsets.<\/jats:p><jats:p>See also pages 3326\u201034.<\/jats:p>","DOI":"10.1002\/cncr.30740","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T12:11:22Z","timestamp":1493727082000},"page":"3222-3225","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic modeling in diffuse large B\u2010cell lymphoma in the era of immunochemotherapy: Where do we go from here?"],"prefix":"10.1002","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-0489","authenticated-orcid":false,"given":"Jean L.","family":"Koff","sequence":"first","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute Emory University Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3990","authenticated-orcid":false,"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute Emory University Atlanta Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_4_2_1","DOI":"10.3322\/caac.21357"},{"doi-asserted-by":"publisher","key":"e_1_2_4_3_1","DOI":"10.3322\/caac.20087"},{"doi-asserted-by":"publisher","key":"e_1_2_4_4_1","DOI":"10.1200\/JCO.2005.09.131"},{"doi-asserted-by":"publisher","key":"e_1_2_4_5_1","DOI":"10.1200\/JCO.2013.51.5866"},{"doi-asserted-by":"publisher","key":"e_1_2_4_6_1","DOI":"10.1002\/cncr.30739"},{"doi-asserted-by":"publisher","key":"e_1_2_4_7_1","DOI":"10.1056\/NEJMoa011795"},{"doi-asserted-by":"publisher","key":"e_1_2_4_8_1","DOI":"10.1038\/35000501"},{"doi-asserted-by":"publisher","key":"e_1_2_4_9_1","DOI":"10.3109\/10428194.2015.1083098"},{"doi-asserted-by":"publisher","key":"e_1_2_4_10_1","DOI":"10.1002\/cncr.28549"},{"doi-asserted-by":"publisher","key":"e_1_2_4_11_1","DOI":"10.1158\/1055-9965.EPI-12-0466"},{"doi-asserted-by":"publisher","key":"e_1_2_4_12_1","DOI":"10.1182\/blood-2003-05-1545"},{"doi-asserted-by":"publisher","key":"e_1_2_4_13_1","DOI":"10.1016\/j.clml.2014.05.002"},{"doi-asserted-by":"publisher","key":"e_1_2_4_14_1","DOI":"10.1182\/blood-2014-05-578963"},{"doi-asserted-by":"publisher","key":"e_1_2_4_15_1","DOI":"10.1200\/JCO.2014.60.2573"},{"key":"e_1_2_4_16_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V128.22.1087.1087","article-title":"Integrative genetic and clinical analysis through whole exome sequencing in 1001 diffuse large B cell lymphoma (DLBCL) patients reveals novel disease drivers and risk groups [abstract]","volume":"128","author":"Zhang J","year":"2016","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"e_1_2_4_17_1","DOI":"10.1182\/blood-2016-01-643569"},{"doi-asserted-by":"publisher","key":"e_1_2_4_18_1","DOI":"10.1182\/blood.V128.22.469.469"},{"key":"e_1_2_4_19_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood.V128.22.470.470","article-title":"Obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B\u2010cell lymphoma: final results from an open\u2010label, randomized phase 3 study (GOYA) [abstract]","volume":"128","author":"Vitolo U","year":"2016","journal-title":"Blood"},{"key":"e_1_2_4_20_1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V126.23.811.811","article-title":"Randomized phase 2 open\u2010label study of R\u2010CHOP\u2009\u00b1\u2009bortezomib in patients (Pts) with untreated non\u2010germinal center B\u2010cell\u2013like (non\u2010GCB) subtype diffuse large cell lymphoma (DLBCL): results from the Pyramid trial [abstract]","volume":"126","author":"Leonard JP","year":"2015","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"e_1_2_4_21_1","DOI":"10.1200\/JCO.2014.55.5714"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30740","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:48:27Z","timestamp":1760269707000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":20,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1002\/cncr.30740"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30740","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}